#1
:max_bytes(150000):strip_icc()/Health-GettyImages-1688221666-08174a5c481b43a5b01c5a8f2d71f3eb.jpg)
#1 out of 1
health17h ago
GLP-1 Drugs May Raise the Risk of Osteoporosis and Gout, Study Suggests
- Latest data show GLP-1 users had a higher osteoporosis diagnosis rate than nonusers over five years.
- Gout diagnoses were more common among GLP-1 users than nonusers in the study.
- Osteomalacia risk also appeared higher among GLP-1 users, 0.2% vs 0.1%.
- Researchers caution that the associations do not prove GLP-1s cause these conditions.
- Experts note weight loss from GLP-1 therapy might influence bone health, not the drugs alone.
- The researchers did not track dosage, adherence, or lifestyle factors in this analysis.
- The findings were presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons.
- Clinicians are advised to monitor bone health during significant weight loss on GLP-1 therapy.
- GLP-1 medications studied include semaglutide drugs Ozempic and Wegovy among others.
- The article notes the potential benefit-risk balance of GLP-1 therapies remains, with heart and metabolic benefits often outweighing risks.
Vote 0